{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:12:34Z","timestamp":1794327154675,"version":"4.9.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Apolipoprotein E<\/jats:italic>\n                      \u03b54 (\n                      <jats:italic>APOE4<\/jats:italic>\n                      ) is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease (LOAD). A recent case report identified a rare variant in APOE,\n                      <jats:italic>APOE3<\/jats:italic>\n                      -R136S (Christchurch), proposed to confer resistance to autosomal dominant Alzheimer\u2019s Disease (AD). However, it remains unclear whether and how this variant exerts its protective effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We introduced the R136S variant into mouse\n                      <jats:italic>Apoe<\/jats:italic>\n                      (\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      ) and investigated its effect on the development of AD-related pathology using the 5xFAD model of amyloidosis and the PS19 model of tauopathy. We used immunohistochemical and biochemical analysis along with single-cell spatial omics and bulk proteomics to explore the impact of the\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      variant on AD pathological development and the brain\u2019s response to plaques and tau.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 5xFAD mice,\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      enhances a Disease-Associated Microglia (DAM) phenotype in microglia surrounding plaques, and reduces plaque load, dystrophic neurites, and plasma neurofilament light chain. By contrast, in PS19 mice,\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      suppresses the microglial and astrocytic responses to tau-laden neurons and does not reduce tau accumulation or phosphorylation, but partially rescues tau-induced synaptic and myelin loss. We compared how microglia responses differ between the two mouse models to elucidate the distinct DAM signatures induced by\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      . We identified upregulation of antigen presentation-related genes in the DAM response in a PS19 compared to a 5xFAD background, suggesting a differential response to amyloid versus tau pathology that is modulated by the presence of\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      . Bulk proteomics show upregulated mitochondrial protein abundance with\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      in 5xFAD mice, but reductions in mitochondrial and translation associated proteins in PS19 mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings highlight the ability of the\n                      <jats:italic>ApoeCh<\/jats:italic>\n                      variant to modulate microglial responses based on the type of pathology, enhancing DAM reactivity in amyloid models and dampening neuroinflammation to promote protection in tau models. This suggests that the Christchurch variant's protective effects likely involve multiple mechanisms, including changes in receptor binding and microglial programming.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-024-00793-x","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:41:31Z","timestamp":1737506491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-7221","authenticated-orcid":false,"given":"Kristine M.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8890-4976","authenticated-orcid":false,"given":"Nellie E.","family":"Kwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-8297","authenticated-orcid":false,"given":"Claire A.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gomez-Arboledas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-4763","authenticated-orcid":false,"given":"Shimako","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-6377","authenticated-orcid":false,"given":"Rocio A.","family":"Barahona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate I.","family":"Tsourmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-5816","authenticated-orcid":false,"given":"Zechuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherilyn","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Xuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-8970","authenticated-orcid":false,"given":"Joshua A.","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc M.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-024X","authenticated-orcid":false,"given":"Andrea J.","family":"Tenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"LaFerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Hohsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Swarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-9501","authenticated-orcid":false,"given":"Grant R.","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6049-6744","authenticated-orcid":false,"given":"Kim N.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"4","key":"793_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"793_CR2","doi-asserted-by":"publisher","first-page":"a006296","DOI":"10.1101\/cshperspect.a006296","volume":"2","author":"RE Tanzi","year":"2012","unstructured":"Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10):a006296.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"793_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","volume":"5","author":"R Sherrington","year":"1996","unstructured":"Sherrington R, et al. Alzheimer\u2019s disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5(7):985\u20138.","journal-title":"Hum Mol Genet"},{"issue":"5226","key":"793_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.7638621","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, et al. A familial Alzheimer\u2019s disease locus on chromosome 1. Science. 1995;269(5226):970\u20133.","journal-title":"Science"},{"issue":"6543","key":"793_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"issue":"6347","key":"793_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin MC, et al. Early-onset Alzheimer\u2019s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991;353(6347):844\u20136.","journal-title":"Nature"},{"issue":"6311","key":"793_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"3","key":"793_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51(3):404\u201313.","journal-title":"Nat Genet"},{"issue":"6","key":"793_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24369","volume":"77","author":"A Serrano-Pozo","year":"2015","unstructured":"Serrano-Pozo A, et al. APOEepsilon2 is associated with milder clinical and pathological Alzheimer disease. Ann Neurol. 2015;77(6):917\u201329.","journal-title":"Ann Neurol"},{"issue":"5123","key":"793_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"key":"793_CR11","doi-asserted-by":"crossref","unstructured":"Nguyen D, Dhanasekaran P, Nickel M, et al. Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E. Biochemistry. 2014;53(24):4025\u201333.","DOI":"10.1021\/bi500340z"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem. 1994;45:249\u2013302.","journal-title":"Adv Protein Chem"},{"issue":"7","key":"793_CR13","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1074\/jbc.M411719200","volume":"280","author":"M Futamura","year":"2005","unstructured":"Futamura M, et al. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J Biol Chem. 2005;280(7):5414\u201322.","journal-title":"J Biol Chem"},{"issue":"42","key":"793_CR14","doi-asserted-by":"publisher","first-page":"39138","DOI":"10.1074\/jbc.M104746200","volume":"276","author":"CP Libeu","year":"2001","unstructured":"Libeu CP, et al. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J Biol Chem. 2001;276(42):39138\u201344.","journal-title":"J Biol Chem"},{"issue":"11","key":"793_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680\u20133.","journal-title":"Nat Med"},{"issue":"7","key":"793_CR16","doi-asserted-by":"publisher","first-page":"e11884","DOI":"10.1371\/journal.pone.0011884","volume":"5","author":"RA Fuentealba","year":"2010","unstructured":"Fuentealba RA, et al. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS ONE. 2010;5(7):e11884.","journal-title":"PLoS ONE"},{"issue":"5","key":"793_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1523\/JNEUROSCI.5491-10.2011","volume":"31","author":"T Kanekiyo","year":"2011","unstructured":"Kanekiyo T, et al. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci. 2011;31(5):1644\u201351.","journal-title":"J Neurosci"},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-beta clearance in Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:93.","journal-title":"Front Aging Neurosci"},{"issue":"49","key":"793_CR19","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","volume":"33","author":"T Kanekiyo","year":"2013","unstructured":"Kanekiyo T, et al. Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci. 2013;33(49):19276\u201383.","journal-title":"J Neurosci"},{"issue":"7803","key":"793_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580(7803):381\u20135.","journal-title":"Nature"},{"issue":"1","key":"793_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1471-4159.1997.69010060.x","volume":"69","author":"SW Barger","year":"1997","unstructured":"Barger SW, Mattson MP. Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein. J Neurochem. 1997;69(1):60\u20137.","journal-title":"J Neurochem"},{"issue":"3","key":"793_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, et al. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and abeta secretion. Cell. 2017;168(3):427\u2013441 e21.","journal-title":"Cell"},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2020.00754","volume":"11","author":"CM Kloske","year":"2020","unstructured":"Kloske CM, Wilcock DM. The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer\u2019s Disease. Front Immunol. 2020;11:754.","journal-title":"Front Immunol"},{"issue":"4","key":"793_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, et al. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron. 1993;11(4):575\u201380.","journal-title":"Neuron"},{"issue":"1","key":"793_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Data. 2021;8(1):270.","journal-title":"Sci Data"},{"key":"793_CR26","doi-asserted-by":"crossref","unstructured":"Guyenet SJ. et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp. 2010;(39):1787.","DOI":"10.3791\/1787"},{"key":"793_CR27","doi-asserted-by":"publisher","first-page":"785276","DOI":"10.3389\/fnins.2021.785276","volume":"15","author":"DI Javonillo","year":"2021","unstructured":"Javonillo DI, et al. Systematic phenotyping and characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease. Front Neurosci. 2021;15:785276.","journal-title":"Front Neurosci"},{"issue":"1","key":"793_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-023-00598-4","volume":"18","author":"KM Tran","year":"2023","unstructured":"Tran KM, et al. A Trem 2(R47H) mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques. Mol Neurodegener. 2023;18(1):12.","journal-title":"Mol Neurodegener"},{"issue":"7673","key":"793_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature"},{"issue":"2","key":"793_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron. 2013;80(2):402\u201314.","journal-title":"Neuron"},{"issue":"2","key":"793_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak G, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278.","journal-title":"Genome Biol"},{"key":"793_CR33","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016. ISBN 978-3-319-24277-4. https:\/\/ggplot2.tidyverse.org."},{"issue":"6","key":"793_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41592-022-01498-z","volume":"19","author":"W Zhang","year":"2022","unstructured":"Zhang W, et al. Identification of cell types in multiplexed in situ images by combining protein expression and spatial information using CELESTA. Nat Methods. 2022;19(6):759\u201369.","journal-title":"Nat Methods"},{"key":"793_CR35","doi-asserted-by":"crossref","unstructured":"Sepulveda-Falla D, et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia. Acta Neuropathol. 2022;144(3):589-601.","DOI":"10.1007\/s00401-022-02467-8"},{"issue":"11","key":"793_CR36","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.neuron.2024.02.009","volume":"112","author":"MC Almeida","year":"2024","unstructured":"Almeida MC, et al. Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer\u2019s disease profile and possible mechanisms of disease protection. Neuron. 2024;112(11):1778\u20131794 e7.","journal-title":"Neuron"},{"key":"793_CR37","doi-asserted-by":"crossref","unstructured":"Dammer EB, NT Seyfried, ECB Johnson. Batch correction and harmonization of -Omics datasets with a tunable median polish of ratio. Front Syst Biol. 2023;3:1092341.","DOI":"10.3389\/fsysb.2023.1092341"},{"issue":"5","key":"793_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","volume":"30","author":"J Fortea","year":"2024","unstructured":"Fortea J, et al. APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med. 2024;30(5):1284\u201391.","journal-title":"Nat Med"},{"issue":"17","key":"793_CR39","doi-asserted-by":"publisher","first-page":"14782","DOI":"10.1074\/jbc.M213207200","volume":"278","author":"H Saito","year":"2003","unstructured":"Saito H, et al. Characterization of the heparin binding sites in human apolipoprotein E. J Biol Chem. 2003;278(17):14782\u20137.","journal-title":"J Biol Chem"},{"issue":"10","key":"793_CR40","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 2014;30(10):1473\u20135.","journal-title":"Bioinformatics"},{"issue":"2","key":"793_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread. Cell. 2024;187(2):428\u2013445 e20.","journal-title":"Cell"},{"issue":"3508","key":"793_CR42","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1126\/science.135.3508.1071","volume":"135","author":"JH Bruell","year":"1962","unstructured":"Bruell JH, Daroczy AF, Hellerstein HK. Strain and sex differences in serum cholesterol levels of mice. Science. 1962;135(3508):1071\u20132.","journal-title":"Science"},{"issue":"3","key":"793_CR43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/j.1460-2075.1990.tb08180.x","volume":"9","author":"M Vidal","year":"1990","unstructured":"Vidal M, et al. Tissue-specific control elements of the Thy-1 gene. EMBO J. 1990;9(3):833\u201340.","journal-title":"EMBO J"},{"issue":"6","key":"793_CR44","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/j.1460-2075.1996.tb00468.x","volume":"15","author":"D Moechars","year":"1996","unstructured":"Moechars D, et al. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 1996;15(6):1265\u201374.","journal-title":"EMBO J"},{"issue":"3","key":"793_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337\u201351.","journal-title":"Neuron"},{"issue":"6","key":"793_CR46","doi-asserted-by":"publisher","first-page":"e21050","DOI":"10.1371\/journal.pone.0021050","volume":"6","author":"H Takeuchi","year":"2011","unstructured":"Takeuchi H, et al. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS ONE. 2011;6(6):e21050.","journal-title":"PLoS ONE"},{"issue":"6","key":"793_CR47","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013;79(6):1094\u2013108.","journal-title":"Neuron"},{"issue":"7","key":"793_CR48","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276\u20131290 e17.","journal-title":"Cell"},{"issue":"2","key":"793_CR49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-210523","volume":"85","author":"A Sil","year":"2022","unstructured":"Sil A, et al. Sex differences in behavior and molecular pathology in the 5XFAD model. J Alzheimers Dis. 2022;85(2):755\u201378.","journal-title":"J Alzheimers Dis"},{"key":"793_CR50","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, et al. Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"issue":"1","key":"793_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, et al. Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron. 2016;91(1):56\u201366.","journal-title":"Neuron"},{"issue":"6","key":"793_CR52","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","volume":"19","author":"M Piwecka","year":"2023","unstructured":"Piwecka M, Rajewsky N, Rybak-Wolf A. Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat Rev Neurol. 2023;19(6):346\u201362.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"793_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13073-022-01075-1","volume":"14","author":"CG Williams","year":"2022","unstructured":"Williams CG, et al. An introduction to spatial transcriptomics for biomedical research. Genome Med. 2022;14(1):68.","journal-title":"Genome Med"},{"issue":"3","key":"793_CR54","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1002\/ctm2.694","volume":"12","author":"D Jovic","year":"2022","unstructured":"Jovic D, et al. Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med. 2022;12(3):e694.","journal-title":"Clin Transl Med"},{"issue":"1","key":"793_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(1):253\u2013271 e6.","journal-title":"Immunity"},{"issue":"3","key":"793_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41593-022-01022-8","volume":"25","author":"SE Marsh","year":"2022","unstructured":"Marsh SE, et al. Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat Neurosci. 2022;25(3):306\u201316.","journal-title":"Nat Neurosci"},{"issue":"3","key":"793_CR57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u2013581 e9.","journal-title":"Immunity"},{"issue":"5","key":"793_CR58","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173(5):1073\u201381.","journal-title":"Cell"},{"key":"793_CR59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fnbeh.2018.00079","volume":"12","author":"FT Gallo","year":"2018","unstructured":"Gallo FT, et al. Immediate early genes, memory and psychiatric disorders: focus on c-Fos, Egr1 and Arc. Front Behav Neurosci. 2018;12:79.","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"793_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/16078454.2020.1867781","volume":"26","author":"XF Sheng","year":"2021","unstructured":"Sheng XF, et al. Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia. Hematology. 2021;26(1):43\u201352.","journal-title":"Hematology"},{"issue":"44","key":"793_CR61","doi-asserted-by":"publisher","first-page":"37171","DOI":"10.1074\/jbc.M112.389916","volume":"287","author":"N Nakaya","year":"2012","unstructured":"Nakaya N, et al. Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth. J Biol Chem. 2012;287(44):37171\u201384.","journal-title":"J Biol Chem"},{"key":"793_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.omto.2021.04.011","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer. Mol Ther Oncolytics. 2021;21:367\u201376.","journal-title":"Mol Ther Oncolytics"},{"key":"793_CR63","doi-asserted-by":"publisher","first-page":"698835","DOI":"10.3389\/fonc.2021.698835","volume":"11","author":"Q Huang","year":"2021","unstructured":"Huang Q, et al. SNAP25 inhibits glioma progression by regulating synapse plasticity via GLS-mediated glutaminolysis. Front Oncol. 2021;11:698835.","journal-title":"Front Oncol"},{"issue":"12","key":"793_CR64","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18(12):759\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"793_CR65","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGFbeta-mediated checkpoints. Nat Immunol. 2023;24(11):1839\u201353.","journal-title":"Nat Immunol"},{"issue":"11","key":"793_CR66","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu CC, et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol. 2023;24(11):1854\u201366.","journal-title":"Nat Immunol"},{"issue":"3","key":"793_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett. 1995;189(3):167\u20139.","journal-title":"Neurosci Lett"},{"issue":"11","key":"793_CR68","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216(11):2546\u201361.","journal-title":"J Exp Med"},{"issue":"9","key":"793_CR69","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze M, et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest. 2020;130(9):4954\u201368.","journal-title":"J Clin Invest"},{"issue":"5421","key":"793_CR70","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1126\/science.284.5421.1805","volume":"284","author":"D Zamanillo","year":"1999","unstructured":"Zamanillo D, et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science. 1999;284(5421):1805\u201311.","journal-title":"Science"},{"issue":"2","key":"793_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0896-6273(00)80051-3","volume":"16","author":"T Kutsuwada","year":"1996","unstructured":"Kutsuwada T, et al. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron. 1996;16(2):333\u201344.","journal-title":"Neuron"},{"issue":"13","key":"793_CR72","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1523\/JNEUROSCI.0640-10.2010","volume":"30","author":"JL Brigman","year":"2010","unstructured":"Brigman JL, et al. Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci. 2010;30(13):4590\u2013600.","journal-title":"J Neurosci"},{"issue":"2","key":"793_CR73","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1523\/JNEUROSCI.3209-06.2006","volume":"27","author":"SH Soderling","year":"2007","unstructured":"Soderling SH, et al. A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci. 2007;27(2):355\u201365.","journal-title":"J Neurosci"},{"issue":"2","key":"793_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25(2):213\u201325.","journal-title":"Nat Neurosci"},{"issue":"8006","key":"793_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature. 2024;628(8006):195\u2013203.","journal-title":"Nature"},{"issue":"12","key":"793_CR76","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson MR, et al. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. Nat Neurosci. 2023;26(12):2104\u201321.","journal-title":"Nat Neurosci"},{"key":"793_CR77","doi-asserted-by":"crossref","unstructured":"Naguib S, Torres ER, Lopez-Lee C, et al. APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition. Preprint. bioRxiv. 2024;2024.04.25.591140.","DOI":"10.2139\/ssrn.4799775"},{"issue":"7","key":"793_CR78","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41556-023-01158-0","volume":"25","author":"I Choi","year":"2023","unstructured":"Choi I, et al. Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol. 2023;25(7):963\u201374.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"793_CR79","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","volume":"263","author":"A Lalazar","year":"1988","unstructured":"Lalazar A, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem. 1988;263(8):3542\u20135.","journal-title":"J Biol Chem"},{"issue":"43","key":"793_CR80","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M. The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J Biol Chem. 2015;290(43):26033\u201342.","journal-title":"J Biol Chem"},{"issue":"43","key":"793_CR81","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, et al. Apolipoprotein E is a ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem. 2015;290(43):26043\u201350.","journal-title":"J Biol Chem"},{"issue":"1","key":"793_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-017-0835-4","volume":"14","author":"C Jendresen","year":"2017","unstructured":"Jendresen C, et al. The Alzheimer\u2019s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway. J Neuroinflammation. 2017;14(1):59.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"793_CR83","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, et al. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91(2):328\u201340.","journal-title":"Neuron"},{"key":"793_CR84","doi-asserted-by":"crossref","unstructured":"Mahley RW, Y Huang, SC Rall Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40(11):1933\u201349.","DOI":"10.1016\/S0022-2275(20)32417-2"},{"issue":"33","key":"793_CR85","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A. 2013;110(33):E3138\u201347.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"793_CR86","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron. 2021;109(15):2413\u20132426 e7.","journal-title":"Neuron"},{"issue":"7638","key":"793_CR87","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"7953","key":"793_CR88","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615(7953):668\u201377.","journal-title":"Nature"},{"issue":"1","key":"793_CR89","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, et al. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"793_CR90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"1","key":"793_CR91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ibra.12023","volume":"8","author":"YH Guan","year":"2022","unstructured":"Guan YH, et al. The role of microglia in Alzheimer\u2019s disease and progress of treatment. Ibrain. 2022;8(1):37\u201347.","journal-title":"Ibrain"},{"key":"793_CR92","doi-asserted-by":"publisher","first-page":"1201982","DOI":"10.3389\/fnagi.2023.1201982","volume":"15","author":"J Miao","year":"2023","unstructured":"Miao J, et al. Microglia in Alzheimer\u2019s disease: pathogenesis, mechanisms, and therapeutic potentials. Front Aging Neurosci. 2023;15:1201982.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"793_CR93","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer\u2019s disease. Biochem Pharmacol. 2014;88(4):594\u2013604.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"793_CR94","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"793_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou AG, Goate AM. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017;12(1):43.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"793_CR96","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","volume":"38","author":"L Rajendran","year":"2018","unstructured":"Rajendran L, Paolicelli RC. Microglia-mediated synapse loss in Alzheimer\u2019s disease. J Neurosci. 2018;38(12):2911\u20139.","journal-title":"J Neurosci"},{"issue":"3","key":"793_CR97","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nn.3641","volume":"17","author":"Y Zhan","year":"2014","unstructured":"Zhan Y, et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci. 2014;17(3):400\u20136.","journal-title":"Nat Neurosci"},{"issue":"6048","key":"793_CR98","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456\u20138.","journal-title":"Science"},{"key":"793_CR99","doi-asserted-by":"crossref","unstructured":"Fassler M, C Benaim, J George. TREM2 agonism with a monoclonal antibody attenuates Tau pathology and neurodegeneration. Cells. 2023;12(11):1549.","DOI":"10.3390\/cells12111549"},{"issue":"661","key":"793_CR100","doi-asserted-by":"publisher","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(661):eabq0095.","journal-title":"Sci Transl Med"},{"issue":"11","key":"793_CR101","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584\u201393.","journal-title":"Nat Neurosci"},{"issue":"1","key":"793_CR102","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, et al. Microglial NF-kappaB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun. 2022;13(1):1969.","journal-title":"Nat Commun"},{"issue":"1","key":"793_CR103","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2010-100681","volume":"22","author":"Y Yoshiyama","year":"2010","unstructured":"Yoshiyama Y, et al. Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J Alzheimers Dis. 2010;22(1):295\u2013306.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"793_CR104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, et al. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2002;9(3):305\u201318.","journal-title":"Neurobiol Dis"},{"key":"793_CR105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","volume":"3","author":"F Liao","year":"2015","unstructured":"Liao F, et al. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathol Commun. 2015;3:70.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-024-00793-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:24:30Z","timestamp":1737548670000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-024-00793-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1186\/s13024-024-00793-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.03.597211","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving mice were approved by the UC Irvine Institutional Animal Care and Use Committee and were conducted in compliance with all relevant ethical regulations for animal testing and research. All experiments involving mice comply with the Animal Research: Reporting of in Vivo Experiments (ARRIVE-10) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KNG is a member of the advisory board of Ashvattha Therapeutics.\u00a0DMD and NTS are co-founders of ARCProteomics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}